ClinicalTrials.Veeva

Menu

Safety and Analgesic Efficacy of a Modified Auriculotemporal Nerve Block

T

Tongji Hospital

Status

Enrolling

Conditions

Safety and Efficacy
Scalp Nerve Block

Treatments

Procedure: Traditional auriculotemporal nerve blockade
Procedure: a modified auriculotemporal nerve blockade

Study type

Interventional

Funder types

Other

Identifiers

NCT05556889
TJ2021S195

Details and patient eligibility

About

  1. Efficacy of a modified auriculotemporal nerve blockade for patients undergoing supratentorial craniotomy
  2. Safety of a modified auriculotemporal nerve blockade for patients undergoing supratentorial craniotomy

Full description

Scalp nerve block for supratentorial craniotomy patients can effectively reduce the consumption of perioperative analgesic drugs, avoid the occurrence of hypertension and tachycardia, relieve postoperative pain, improve postoperative recovery quality of patients. Scalp nerve block is safe and has fewer complications due to the small amount of local anesthetic. For auriculotemporal nerve block, temporary block of adjacent facial nerve is one of the most likely complications, with an incidence of 8.6%, and usually can be recovered within 24 hours, since the facial nerve was located in the anterior and lower part of the tragus, 1 cm deep in the skin. Therefore, improving nerve block methods and reducing the dosage of local anesthetics may reduce the risk of facial nerve block. The investigators proposed helix feet in front of the zygomatic arch as anatomy marks of auriculotemporal nerve block, and the modified auriculotemporal nerve blockade is implemented as follows: Zygomatic arch level, posterior to the superficial temporal artery, the vertical puncture depth is about 0.5 -1 cm, and 2 ml of local anesthetics are injected after withdrawing without blood. The study intends to compare a modified auriculotemporal nerve block method with the traditional way, reflecting on perioperative hemodynamical fluctuation, postoperative analgesia effect and incidence of facial nerve paralysis. This will verify the safety and analgesic efficacy of the modified nerve block method proposed in this study, and then provide a basis for improving the quality of perioperative management during neurosurgery.

Enrollment

252 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients undergoing supratentorial craniotomy under general anesthesia;
  2. 18-65 years old;
  3. ASA I or II.

Exclusion criteria

  1. Emergency surgery;
  2. Be allergic to ropivacaine;
  3. Participating in other clinical investigation within 30 days;
  4. Skin infection at the puncture site;
  5. Patients taking analgesic drugs before surgery;
  6. Persons addicted to alcohol or drugs;
  7. Patients with severe liver and kidney dysfunction;
  8. Patients with coagulation disorder;
  9. Pregnant and lactating women;
  10. Patients with consciousness disorder before surgery;
  11. Those who have undergone neurosurgery within the last 6 months;
  12. Patients who were unable to understand the NRS before surgery.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

252 participants in 2 patient groups

a modified auriculotemporal nerve blockade
Experimental group
Description:
Helix feet in front of the zygomatic arch is served as anatomy marks of auriculotemporal nerve block, and the modified auriculotemporal nerve blockade is implemented as follows: Zygomatic arch level, posterior to the superficial temporal artery, the vertical puncture depth is about 0.5 -1 cm, and 2 ml of local anesthetics are injected after withdrawing without blood.
Treatment:
Procedure: a modified auriculotemporal nerve blockade
Traditional auriculotemporal nerve blockade
Other group
Description:
The traditional method of auriculotemporal nerve block is to inject the needle 1\~1.5 cm vertically at the level of tragus and posterior of superficial temporal artery, and inject 2-3 ml of local anesthetics after pumping back without blood
Treatment:
Procedure: Traditional auriculotemporal nerve blockade

Trial contacts and locations

1

Loading...

Central trial contact

Feng Gao

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems